UnitedHealth Group Inc (NYSE:UNH) Shares Bought by Oakworth Capital Inc.

Oakworth Capital Inc. boosted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 5.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,377 shares of the healthcare conglomerate’s stock after buying an additional 179 shares during the quarter. Oakworth Capital Inc.’s holdings in UnitedHealth Group were worth $824,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. FMR LLC lifted its holdings in UnitedHealth Group by 1.9% during the fourth quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock valued at $16,063,258,000 after purchasing an additional 1,232,189 shares in the last quarter. Geode Capital Management LLC lifted its holdings in UnitedHealth Group by 9.1% during the fourth quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after purchasing an additional 965,763 shares in the last quarter. Norges Bank purchased a new position in UnitedHealth Group during the fourth quarter valued at $2,343,175,000. Janus Henderson Group PLC lifted its holdings in UnitedHealth Group by 16.7% during the second quarter. Janus Henderson Group PLC now owns 6,448,289 shares of the healthcare conglomerate’s stock valued at $1,573,438,000 after purchasing an additional 922,290 shares in the last quarter. Finally, Legal & General Group Plc lifted its holdings in UnitedHealth Group by 9.0% during the fourth quarter. Legal & General Group Plc now owns 4,747,709 shares of the healthcare conglomerate’s stock valued at $1,182,721,000 after purchasing an additional 391,437 shares in the last quarter. Institutional investors own 85.65% of the company’s stock.

In related news, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total transaction of $2,419,900.00. Following the completion of the sale, the director now directly owns 187,663 shares in the company, valued at $45,412,569.37. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of the firm’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the sale, the director now owns 61,309 shares of the company’s stock, valued at $15,652,800.79. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 37,000 shares of company stock valued at $9,195,620. 0.87% of the stock is owned by company insiders.

Several equities analysts have issued reports on UNH shares. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a report on Friday, July 12th. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. Cantor Fitzgerald set a $310.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Royal Bank of Canada set a $311.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Finally, Oppenheimer set a $312.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $295.06.

UnitedHealth Group stock traded up $1.44 during midday trading on Friday, hitting $245.69. 2,784,100 shares of the stock were exchanged, compared to its average volume of 3,303,574. UnitedHealth Group Inc has a fifty-two week low of $208.07 and a fifty-two week high of $287.94. The stock has a market capitalization of $231.47 billion, a price-to-earnings ratio of 19.08, a PEG ratio of 1.30 and a beta of 0.61. The stock’s 50-day simple moving average is $251.25 and its 200 day simple moving average is $247.71. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The firm had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. During the same period last year, the business earned $3.14 earnings per share. UnitedHealth Group’s revenue was up 8.0% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Inc will post 14.84 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.76%. The ex-dividend date of this dividend is Friday, September 13th. UnitedHealth Group’s payout ratio is currently 33.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: Buy-Side Analysts

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.